Trial site
L'Azienda Ospedaliera Di Rilievo Nazionale Santobono-Pausilipon
Naples, 80129, ItalyNot linked to an institution yet
- 8running trials
- 2closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Phase
- Phase 36 trials
- Phase 24 trials
- Phase 2/32 trials
- Status
- Active, not recruiting7 trials
- Completed2 trials
- Suspended2 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company1 trial
- Fondazione IRCCS Istituto Nazionale Dei Tumori1 trial
- GPOH gGmbH1 trial
- Hoffmann-La Roche1 trial
- Martin Schrappe1 trial
- and 7 more
Running trials
Active, not recruiting
A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy
NCT06413706· Phase 2· Eli Lilly and Company· Source
Active, not recruiting
LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis
NCT02205762· Phase 2/3· St. Anna Childrens Cancer Research Institute GmbH· Source
Recruiting
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
NCT05327894· Phase 3· Princess Maxima Center for Pediatric Oncology· Source
Active, not recruiting
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors
NCT04431726· Phase 3· Hoffmann-La Roche· Source
Active, not recruiting
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
NCT03591510· Phase 2· Novartis Pharmaceuticals· Source
Recruiting
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
NCT03643276· Phase 3· Martin Schrappe· Source
Active, not recruiting
Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
NCT03407144· Phase 2· Merck Sharp & Dohme LLC· Source
Active, not recruiting
Phase 2 open label randomized study of radiotherapy, concomitant nimotuzumab and vinorelbine and re-irradiation at relapse versus radiotherapy and multiple elective radiotherapy courses with concomitant vinorelbine and nimotuzumab for newly diagnosed childhood and adolescence diffuse intrinsic pontine glioma (DIPG).
2024-513654-30-00· Phase 2· Fondazione IRCCS Istituto Nazionale Dei Tumori· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error